Online citations, reference lists, and bibliographies.
← Back to Search

‘Multicopy Multivalent’ Glycopolymer-Stabilized Gold Nanoparticles As Potential Synthetic Cancer Vaccines

A. L. Parry, Natasha A. Clemson, J. Ellis, S. Bernhard, B. Davis, N. Cameron
Published 2013 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Mucin-related carbohydrates are overexpressed on the surface of cancer cells, providing a disease-specific target for cancer immunotherapy. Here, we describe the design and construction of peptide-free multivalent glycosylated nanoscale constructs as potential synthetic cancer vaccines that generate significant titers of antibodies selective for aberrant mucin glycans. A polymerizable version of the Tn-antigen glycan was prepared and converted into well-defined glycopolymers by Reversible Addition–Fragmentation chain Transfer (RAFT) polymerization. The polymers were then conjugated to gold nanoparticles, yielding ‘multicopy-multivalent’ nanoscale glycoconjugates. Immunological studies indicated that these nanomaterials generated strong and long-lasting production of antibodies that are selective to the Tn-antigen glycan and cross-reactive toward mucin proteins displaying Tn. The results demonstrate proof-of-concept of a simple and modular approach toward synthetic anticancer vaccines based on multivalent glycosylated nanomaterials without the need for a typical vaccine protein component.
This paper references
10.1016/J.POLYMER.2007.11.020
Radical addition-fragmentation chemistry in polymer synthesis
G. Moad (2008)
10.1002/1521-3773(20020503)41:9<1554::AID-ANIE1554>3.0.CO;2-3
A model system mimicking glycosphingolipid clusters to quantify carbohydrate self-interactions by surface plasmon resonance.
M. Hernáiz (2002)
10.1002/(SICI)1521-3773(20000303)39:5<836::AID-ANIE836>3.0.CO;2-I
From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix.
Danishefsky (2000)
10.1002/anie.201000462
Fully synthetic vaccines consisting of tumor-associated MUC1 glycopeptides and a lipopeptide ligand of the Toll-like receptor 2.
A. Kaiser (2010)
10.1016/J.MOLIMM.2004.04.008
B cell antigen receptor signaling 101.
J. D. Dal Porto (2004)
10.1021/ar800075n
Toward living radical polymerization.
G. Moad (2008)
Polym. Chem. J. Polym. Sci., Part A: Polym. Chem. Eur. Polym. J
S R S Ting (1392)
J. Am. Chem. Soc
M Eaton (2005)
Carbohydr. Res. N. R. Polym. Chem
R Ojeda (1513)
10.1016/j.cbpa.2009.08.010
Recent development in carbohydrate-based cancer vaccines.
Zhongwu Guo (2009)
10.1039/C0PY00149J
A spoonful of sugar: the application of glycopolymers in therapeutics
Sebastian G Spain (2011)
Cancer Res Int. J. Cancer Scher, H. I. Cancer Immunol. Immunother. Cancer Res
U S A Sci (2000)
10.1002/chem.201100217
Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
H. Cai (2011)
10.1093/glycob/cwq085
Over-expression of ST3Gal-I promotes mammary tumorigenesis
G. Picco (2010)
J. Am. Chem. Soc. N. R.; Davis, B. G. Proc. Natl. Acad. Sci. U.S.A
(2009)
Chem. Soc. Angew. Chem., Int. Ed. Boons, G. J. Angew. Chem., Int. Ed
Soc Ragupathi (2005)
10.1021/MA049269J
Amphiphilic Gold Nanoparticles Grafted with Poly(N-isopropylacrylamide) and Polystyrene
J. Shan (2005)
10.1021/ja9052625
A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.
Insik Jeon (2009)
10.1021/LA026872R
Synthesis of Gold Nanoparticles Grafted with a Thermoresponsive Polymer by Surface-Induced Reversible-Addition-Fragmentation Chain-Transfer Polymerization
Janne Raula (2003)
10.1016/j.jmb.2011.03.042
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
M. Marradi (2011)
Langmuir Macromolecules
J Shan (2003)
10.1016/S0952-7915(02)00344-8
Regulation of B cell fates by BCR signaling components.
T. Kurosaki (2002)
10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S
Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions.
J. M. de la Fuente (2001)
10.1002/ANIE.200700964
Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin.
S. Wittrock (2007)
10.1073/pnas.051626298
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial
T. Gilewski (2001)
Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
K. O’Boyle (2006)
J.; Buskas, T.; Boons, G. J. Nat. Chem. Biol
Chem (2007)
10.1039/C0PY00141D
Synthesis of glycopolymers and their multivalent recognitions with lectins
S. Ting (2010)
10.1016/S0040-4039(98)01702-X
DPPE: A convenient replacement for triphynylphosphine in the staudinger and Mitsunobu reactions
I. O'neil (1998)
J. Mol. Immunol
E Cambier (2004)
Angew. Chem., Int. Ed
S Wittrock (2007)
10.1038/NCHEMBIO.2007.25
Robust immune responses elicited by a fully synthetic three-component vaccine.
S. Ingale (2007)
10.1021/JA9825128
Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer†
S. Kuduk (1998)
10.1021/JA020556H
Facile preparation of transition metal nanoparticles stabilized by well-defined (co)polymers synthesized via aqueous reversible addition-fragmentation chain transfer polymerization.
A. B. Lowe (2002)
Curr. Opin. Immunol
(2002)
10.1016/J.EURPOLYMJ.2003.10.019
Synthetic glycopolymers: an overview
V. Ladmiral (2004)
J.; Burchell, J. Glycobiology
G Picco (1241)
10.1021/bc200606s
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Raymond P. Briñas (2012)
10.1002/POLA.22106
Recent advances in the synthesis of well-defined glycopolymers
Sebastian G Spain (2007)
10.1002/1097-0215(20000701)87:1<79::AID-IJC12>3.0.CO;2-L
Immunization of ovarian cancer patients with a synthetic Lewisy‐protein conjugate vaccine: A phase 1 trial
P. Sabbatini (2000)
Nanomedicine Biochim. Biophys. Acta Carbohydr. Res. Tetrahedron: Asymmetry Angew. Chem., Int. Ed. Angew. Chem., Int. Ed
A G Barrientos (1554)
10.2217/nnm.10.48
Glyconanoparticles: multifunctional nanomaterials for biomedical applications.
I. García (2010)
10.1016/J.CARRES.2006.11.018
Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines.
Rafael Ojeda (2007)
10.1021/JA057244+
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.
G. Ragupathi (2006)
Journal of the American Chemical Society Communication dx. J. Am. Chem. Soc
(2013)
10.1002/anie.200802102
Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response.
Ulrika Westerlind (2008)
10.1016/B978-0-12-405191-1.00012-0
Synthesis
P. Wakeley (2013)
10.1016/J.TETASY.2004.12.003
Synthesis of gold nanoparticles bearing the Thomsen–Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen
Sergei A. Svarovsky (2005)
10.1007/s00262-004-0598-5
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
Susan F. Slovin (2004)
Tetrahedron Lett
I A Neil (1998)
Anal. Chem
G.-L Yu (2010)
10.1002/anie.201003810
Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue.
A. Hoffmann-Röder (2010)
10.1038/nmat2766
Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging.
S. Y. Hong (2010)
Angew. Chem., Int. Ed
A Hoffmann-Roder (2010)
Proc. Natl. Acad
S F Slovin (1999)
Thang, S. H. Acc. Chem. Res. Polymer J. Am. Chem. Soc
J Chiefari (1079)
10.1021/JA0431354
Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction.
J. M. de la Fuente (2005)
10.1073/PNAS.96.10.5710
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
S. Slovin (1999)
Angulo, J.; Penades, S. J. Mol. Biol
G Riese (2004)
Angew. Chem., Int. Ed. Chem. Commun. Curr. Opin. Chem. Biol
S J Danishefsky (2000)
10.1073/pnas.0806787106
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease
S. V. van Kasteren (2009)
10.1021/ac102300r
Effect and limitation of excess ammonium on the release of O-glycans in reducing forms from glycoproteins under mild alkaline conditions for glycomic and functional analysis.
Guangli Yu (2010)
10.1002/ANIE.200501818
Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Therese Buskas (2005)
10.1002/CHEM.200204544
Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies.
A. Barrientos (2003)
10.1002/cbic.200300726
Gold Glyconanoparticles as New Tools in Antiadhesive Therapy
Javier Rojo (2004)
10.1039/b908664c
Immunotherapy for cancer: synthetic carbohydrate-based vaccines.
Therese Buskas (2009)
10.1158/1078-0432.CCR-04-0482
Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin
L. Krug (2004)
10.1158/1078-0432.CCR-06-2949
Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
P. Sabbatini (2007)
J. Am. Chem. Soc
S D Kuduk (1998)
10.1016/J.BBAGEN.2005.12.001
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science.
J. M. de la Fuente (2006)
10.1021/MA9804951
Living free-radical polymerization by reversible addition - Fragmentation chain transfer: The RAFT process
J. Chiefari (1998)
10.1016/j.carres.2008.05.003
Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles.
Andreas Sundgren (2008)



This paper is referenced by
10.1159/000471912
Glycobiology Modifications in Intratumoral Hypoxia: The Breathless Side of Glycans Interaction
Antônio F. Silva-Filho (2017)
10.1039/C6CC04445J
Opportunities for glyconanomaterials in personalized medicine.
Niels-Christian Reichardt (2016)
Interactive RAFT polymer-decorated gold nanoparticles for biomedical use
Zhiyue Zhang (2016)
10.1039/C4MD00097H
New glycopolymers as multivalent systems for lectin recognition
Michele Fiore (2014)
10.1016/j.bbcan.2015.08.003
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Seema Chugh (2015)
10.1002/9781118860212.CH13
Carbohydrate Nanotechnology and its Applications for the Treatment of Cancer
Shailesh Ambre (2015)
10.3390/vaccines4020018
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems
Ru Wen (2016)
10.1002/marc.201600242
Ratiometric Fluorescent pH Probes Based on Glycopolymers.
Zhiyun Li (2016)
10.1021/jacs.5b00592
Probing cell-surface carbohydrate binding proteins with dual-modal glycan-conjugated nanoparticles.
Sungjin Park (2015)
10.3390/molecules24081450
Using Self-Assembling Peptides to Integrate Biomolecules into Functional Supramolecular Biomaterials
Renjie Liu (2019)
10.1016/j.bmc.2016.01.044
Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein.
H. Cai (2016)
10.1039/C5PY01954K
Facile fabrication of glycopolymer-based iron oxide nanoparticles and their applications in the carbohydrate–lectin interaction and targeted cell imaging
C. Shao (2016)
10.1134/S107036321902021X
Synthesis of Gold Glyconanoparticles Based on Thiol-Containing d-Hexose Acylhydrazones and Their Modification by Thiolated Poly(2-deoxy-2-methacryloylamino-D-glucose)
A. Yu. Ershov (2019)
10.1002/9781118860212.CH3
Carbohydrate‐Modified Gold Nanoparticles
M. Thygesen (2015)
10.1016/j.jconrel.2017.04.024
Effects of gold nanoparticle‐based vaccine size on lymph node delivery and cytotoxic T‐lymphocyte responses
Sukmo Kang (2017)
10.1021/acs.bioconjchem.7b00502
Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.
Hamilton Kakwere (2017)
10.1016/j.nano.2017.11.009
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.
N. Climent (2018)
10.1039/C5PY00089K
Glyconanoparticles and their interactions with lectins
G. Yilmaz (2015)
10.1039/c6cc00501b
Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination.
Ze Zhang (2016)
10.1586/14760584.2014.936852
Oral delivery of nanoparticle-based vaccines
Nirmal Marasini (2014)
10.1002/9781118860212.CH14
Carbohydrate Nanotechnology Applied to Vaccine Development
Rajesh Sunasee (2015)
10.1021/ja407033x
Polymerization-Induced Self-Assembly of Galactose-Functionalized Biocompatible Diblock Copolymers for Intracellular Delivery
V. Ladmiral (2013)
10.1021/acschembio.6b00084
Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
Danyang Feng (2016)
10.1002/med.21420
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Erika Dosekova (2017)
10.1021/acs.biomac.7b00228
Specific and Differential Binding of N-Acetylgalactosamine Glycopolymers to the Human Macrophage Galactose Lectin and Asialoglycoprotein Receptor.
Joji Tanaka (2017)
10.1021/ACSMACROLETT.7B00659
Fluorescent Glyco Single-Chain Nanoparticle-Decorated Nanodiamonds
Kilian N. R. Wuest (2017)
10.1016/J.CCLET.2015.05.022
A facile approach to prepare hybrid nanoparticles with morphology controlled by the thickness of glyco-shell
Weiyi Zhang (2015)
10.3762/bjnano.11.39
Preparation and in vivo evaluation of glyco-gold nanoparticles carrying synthetic mycobacterial hexaarabinofuranoside
G. Burygin (2020)
10.3390/molecules191219751
Post-Polymerization Modification of Poly(l-glutamic acid) with d-(+)-Glucosamine
Peter Perdih (2014)
10.1021/acs.chemrev.5b00247
Glycopolymer Nanobiotechnology.
Y. Miura (2016)
10.1007/978-1-4939-2874-3_10
Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines.
Fabrizio Chiodo (2015)
10.3389/fchem.2015.00040
CNS active O-linked glycopeptides
E. M. Jones (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar